Calidi Biotherapeutics (CLDI) Misses Q1 EPS by 43c May 14, 2026 05:54PM
Calidi Biotherapeutics presents data on tumor-targeted therapy at AACR meeting Apr 20, 2026 08:02AM
Calidi Biotherapeutics to present RedTail platform data at conference Apr 14, 2026 08:04AM
Calidi Biotherapeutics (CLDI) Misses Q3 EPS by 221c Nov 13, 2025 07:00PM
Calidi Biotherapeutics prices $6 million public offering Aug 20, 2025 09:16AM


Aug 11, 2025 06:30AM Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $1.99
Jul 29, 2025 08:01AM Calidi Biotherapeutics receives FDA fast track designation for CLD-201
Jul 25, 2025 04:49PM Calidi Biotherapeutics (CLDI) announces 1:12 reverse share split
Jul 9, 2025 02:03PM Calidi Biotherapeutics raises $4.6 million through warrant exercise
May 14, 2025 06:18PM Calidi Biotherapeutics (CLDI) Misses Q1 EPS by 18c
Apr 23, 2025 08:00AM Calidi Biotherapeutics (CLDI) Announces CEO Change
Jan 8, 2025 04:02PM Calidi Biotherapeutics (CLDI) Announces Proposed Public Offering
Nov 13, 2024 04:59PM Calidi Biotherapeutics, Inc. (CLDI) Misses Q3 EPS by 46c
Nov 13, 2024 04:33PM Calidi Biotherapeutics (CLDI) Announces Proposed Public Offering
Oct 23, 2024 08:33AM Calidi Biotherapeutics (CLDI) Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
Oct 17, 2024 12:27PM Calidi Biotherapeutics (CLDI) Halted, News Pending
Oct 7, 2024 04:33PM Calidi Biotherapeutics (CLDI) Files $25M Mixed Shelf
Sep 9, 2024 06:20AM Calidi Biotherapeutics Inc (CLDI) PT Lowered to $2.50 at Baird
Aug 14, 2024 03:57PM Calidi Biotherapeutics, Inc. (CLDI) Misses Q2 EPS by 121c
Jul 5, 2024 04:20PM Calidi Biotherapeutics (CLDI) Announces 1:10 Reverse Share Split
Jun 27, 2024 07:03AM Calidi Biotherapeutics (CLDI) Appoints George Peoples to its Board